←back to thread

FTC challenges 'junk' patents held by 10 drugmakers, incl Novo Nordisk's Ozempic

(www.cnbc.com)
152 points toomuchtodo | 1 comments | 30 Apr 24 21:06 UTC | HN request time: 0.401s | source
Show context
akira2501 ◴[30 Apr 24 21:33 UTC] No.40216636[source]▶
Good.

They patented inhalers for a second time. It's the exact same drug. The only thing that changed was the propellant. It went from R-12 to R-134a. Everyone who had to switch out R-12 from refrigeration to drug manufacturing switched to R-134a. There was absolutely _nothing_ novel about it.

It was _criminal_ to allow them the second patent for just the propellant change. It took generic $5 inhalers off the market and replaced them with $95 inhalers. It was was one of the most corrupt swindles I've ever personally seen.

replies(4): >>40216858 #>>40216885 #>>40217053 #>>40241727 #
RheingoldRiver ◴[30 Apr 24 21:52 UTC] No.40216858[source]▶
> It took generic $5 inhalers off the market and replaced them with $95 inhalers.

OOTL, what is stopping companies from making generics of the older version & patients just not using the new version?

replies(4): >>40216891 #>>40216937 #>>40216991 #>>40217174 #
chemeng ◴[30 Apr 24 21:55 UTC] No.40216891[source]▶
It is illegal to use the previous propellant, so they can’t be manufactured anymore.
replies(1): >>40216938 #
chroma ◴[30 Apr 24 22:00 UTC] No.40216938[source]▶
Where can I read more about this? If that’s true, it seems like a problem of over-regulation, not drug companies being exploitative.
replies(7): >>40216969 #>>40216978 #>>40216994 #>>40217022 #>>40217064 #>>40217065 #>>40217119 #
1. dylan604 ◴[30 Apr 24 22:12 UTC] No.40217065[source]▶
It is true, which implies your understanding of the situation is confused. I dislike bigPharma as well, but I at least point the blame canon at the right target and not just indiscriminately point it at the person I dislike the most in the fight.